VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CLRB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CLRBCellectar Biosciences, Inc.
$2.77$9M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCLRBQuarterly Financials

Cellectar Biosciences, Inc. (CLRB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Cellectar Biosciences, Inc. (CLRB) quarterly income statement — complete revenue, gross profit & net income history

CLRB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold-110.02K0000000000000000000
COGS % of Revenue--------------------
Gross Profit110.02K0000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses5.9M5.69M4.85M6.04M6.4M12.74M13.33M13.7M12M12.55M9.41M8.29M8.71M7.42M7.82M7.44M6.14M5.92M5.82M6.03M
OpEx % of Revenue--------------------
Selling, General & Admin2.9M2.53M2.33M3.65M2.97M6.54M7.83M6.36M4.91M4.61M2.38M2.16M2.35M1.97M2.44M2.94M2.25M1.54M1.88M1.4M
SG&A % of Revenue--------------------
Research & Development3.01M3.16M2.52M2.39M3.43M6.21M5.49M7.35M7.09M7.94M7.03M6.14M6.36M5.45M5.38M4.5M3.89M4.39M3.94M4.63M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-5.79M-5.69M-4.85M-6.04M-6.4M-12.74M-13.33M-13.7M-12M-12.55M-9.41M-8.29M-8.71M-7.42M-7.82M-7.44M-6.14M-5.92M-5.82M-6.03M
Operating Margin %--------------------
Operating Income Growth %9.48%55.35%63.6%55.94%46.66%-1.57%-41.58%-65.22%-37.86%-69.05%-20.45%-11.55%-41.77%-25.31%-34.29%-23.34%3.45%-55.9%-48.84%-66.44%
EBITDA-5.9M-5.64M-4.8M-5.98M-6.34M-12.68M-13.26M-13.64M-11.91M-12.48M-9.37M-8.26M-8.66M-7.38M-7.78M-7.4M-6.1M-5.88M-5.78M-5.99M
EBITDA Margin %--------------------
EBITDA Growth %6.95%55.5%63.81%56.14%46.74%-1.59%-41.47%-65.2%-37.52%-68.98%-20.43%-11.53%-42.09%-25.5%-34.58%-23.57%3.6%-56.34%-49.27%-67.01%
D&A (Non-Cash Add-back)-110.02K49.46K52.28K55.56K56.3K68.57K68.57K66.02K88.49K69.96K41.21K38.65K42.56K38.16K32.96K33.9K43.42K39.29K36.79K38.7K
EBIT-5.79M-5.69M-4.85M-6.04M-6.4M-12.74M-13.33M-13.7M-12M-12.55M-9.41M-8.29M-8.71M-7.42M-7.82M-7.44M-6.14M-5.92M-5.82M-6.03M
Net Interest Income63K97.58K112.54K88.02K136.96K244.21K317.89K328.91K319.85K139.22K51.11K72.78K124.03K147.44K4.16K4814300590659
Interest Income63K97.58K112.54K88.02K136.96K244.21K317.89K328.91K319.85K139.22K51.11K72.78K124.03K147.44K4.16K4814300590659
Interest Expense00000000000000000000
Other Income/Expense140K395.41K406.82K589.62K-203.04K10.46M-1.34M12.78M-14.64M4.61M-8.11M-1.88M1.51M-5.04M4.16K4814305.31K590659
Pretax Income-5.65M-5.3M-4.44M-5.45M-6.6M-2.29M-14.66M-919.37K-26.64M-7.94M-17.52M-10.18M-7.19M-12.47M-7.81M-7.44M-6.14M-5.92M-5.82M-6.03M
Pretax Margin %--------------------
Income Tax0000066K000-60K000-60K000000
Effective Tax Rate %0%0%0%0%0%-2.88%0%0%0%0.76%0%0%0%0.48%0%0%0%0%0%0%
Net Income-5.65M-5.3M-4.44M-5.45M-6.6M-2.36M-14.66M-919.37K-26.64M-7.88M-17.52M-10.18M-7.19M-12.41M-7.81M-7.44M-6.14M-5.92M-5.82M-6.03M
Net Margin %--------------------
Net Income Growth %14.39%-124.81%69.7%-492.57%75.21%70.11%16.3%90.97%-270.52%36.48%-124.29%-36.9%-17.11%-109.64%-34.24%-23.34%3.42%-63.71%-48.84%-66.89%
Net Income (Continuing)-5.65M-5.3M-4.44M-5.45M-6.6M-2.36M-14.66M-919.37K-26.64M-7.88M-17.52M-10.18M-7.19M-12.41M-7.81M-7.44M-6.14M-5.92M-5.82M-6.03M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.33-1.25-1.41-3.39-4.30-1.68-11.18-5.43-27.24-12.17-46.48-27.12-19.16-40.00-38.35-36.51-30.15-29.06-29.16-34.28
EPS Growth %69.07%25.6%87.39%37.57%84.21%86.2%75.94%79.97%-42.18%69.56%-21.19%25.72%36.46%-37.64%-31.52%-6.51%23.91%-21.76%34.55%56.37%
EPS (Basic)-1.33-1.25-1.41-3.39-4.30-1.68-11.18-0.77-27.24-12.17-46.48-27.12-19.16-40.00-38.35-36.51-30.15-29.06-29.16-34.28
Diluted Shares Outstanding4.24M4.24M3.16M1.61M1.54M1.4M1.31M1.25M978.22K647.37K376.96K375.37K375.37K310.2K203.67K203.67K203.67K203.67K199.56K175.88K
Basic Shares Outstanding4.24M4.24M3.16M1.61M1.54M1.4M1.31M169K978.22K647.37K376.96K375.37K375.37K310.2K203.67K203.67K203.67K203.67K199.56K175.88K
Dividend Payout Ratio--------------------